Currently Enrolling Clinical Trials
Jennerex is currently recruiting for the following studies:
Colorectal Cancer
A Phase 1/2a Dose-escalation Study of Pexa-Vec (JX-594) Administered by Multiple Intravenous (IV) Infusions Followed by Intratumoral (IT) Boosts Alone and in Combination with Irinotecan in Patients with Metastatic, Refractory Colorectal Carcinoma.
Clinicaltrials.gov identifier: NCT01394939
Kidney Cancer
A Single-Arm Phase 2 Study of Pexa-Vec (JX-594) Administered by Weekly Intravenous (IV) Infusions in Patients with Metastatic, Refractory Renal Cell Carcinoma (RCC)*
*Investigator Initiated study
Ovarian Cancer*
A Single-Arm, Open-Label Phase 2 Study of Pexa-Vec (JX-594) Administered by 5 Weekly Intravenous (IV) Infusions in Patients with Peritoneal Carcinomatosis of Ovarian Cancer Origin* - not yet recruiting
*Investigator Initiated study
Patients, Advocates and Medical Professionals:
For more information:
http://www.clinicaltrials.gov
